Article in ACS chemical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 14 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 1 institution in 1 country.
Yusha LiuDepartment of Psychiatry and Behavioral Sciences , University of Washington , Seattle , Washington 98104 , United States.
Alec W GibsonDepartment of Psychiatry and Behavioral Sciences , University of Washington , Seattle , Washington 98104 , United States.ORCID 0000-0002-5709-4146
Marjorie R LevinsteinDepartment of Psychiatry and Behavioral Sciences , University of Washington , Seattle , Washington 98104 , United States.
Atom J LesiakDepartment of Psychiatry and Behavioral Sciences , University of Washington , Seattle , Washington 98104 , United States.
Shao-En OngDepartment of Pharmacology , University of Washington , Seattle , Washington 98104 , United States.
John F NeumaierDepartment of Psychiatry and Behavioral Sciences , University of Washington , Seattle , Washington 98104 , United States.
University of Washington · US
Funding
University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic DepressionP50MH106428 · NIMH · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2015 to 2019
$7.6M
Reimbursement request for attending the Meeting of the Jointly Sponsored Institutional Predoctoral Training in the Neurosciences T32 Program Directors in Baltimore, MD on 2/19/19T32NS099578 · NINDS · UNIVERSITY OF WASHINGTON · PI SULLIVAN, JANE M, WONG, RACHEL O · 2016 to 2020
$1.4M
A conditional, tissue specific 5-HT1B knockout mouseR21MH099748 · NIMH · UNIVERSITY OF WASHINGTON · PI NEUMAIER, JOHN F · 2013 to 2014
$425k
Pathway-Selective Modulation of Cocaine Self-Administration by 5-HT6 Receptors and Type III Adenylyl CyclaseF30DA043941 · NIDA · UNIVERSITY OF WASHINGTON · PI GIBSON, ALEC WILTON · 2017 to 2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.